Drug Type ASO |
Synonyms- |
Target |
Mechanism GYS1 gene inhibitors, RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lafora Disease | Phase 2 | US | 01 Dec 2024 |